Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy
Radiological imaging is an integral component of cancer care, including diagnosis, staging,
and treatment response monitoring. It contains rich information about tumor phenotypes that …
and treatment response monitoring. It contains rich information about tumor phenotypes that …
The era of radiogenomics in precision medicine: an emerging approach to support diagnosis, treatment decisions, and prognostication in oncology
L Shui, H Ren, X Yang, J Li, Z Chen, C Yi, H Zhu… - Frontiers in …, 2021 - frontiersin.org
With the rapid development of new technologies, including artificial intelligence and genome
sequencing, radiogenomics has emerged as a state-of-the-art science in the field of …
sequencing, radiogenomics has emerged as a state-of-the-art science in the field of …
Radiomics and radiogenomics for precision radiotherapy
Imaging plays an important role in the diagnosis and staging of cancer, as well as in
radiation treatment planning and evaluation of therapeutic response. Recently, there has …
radiation treatment planning and evaluation of therapeutic response. Recently, there has …
[HTML][HTML] Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: A narrative review
J Li, J Wu, Z Zhao, Q Zhang, J Shao… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Objective In this review, we aim to present frontier studies in patients with lung cancer as it
related to artificial intelligence (AI)-assisted decision-making and summarize the latest …
related to artificial intelligence (AI)-assisted decision-making and summarize the latest …
Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes
Radiomics has shown potential in disease diagnosis, but its feasibility for non-small cell lung
carcinoma (NSCLC) subtype classification is unclear. This study aims to explore the …
carcinoma (NSCLC) subtype classification is unclear. This study aims to explore the …
Selection of external beam radiotherapy approaches for precise and accurate cancer treatment
Physically precise external-beam radiotherapy (EBRT) technologies may not translate to the
best outcome in individual patients. On the other hand, clinical considerations alone are …
best outcome in individual patients. On the other hand, clinical considerations alone are …
[HTML][HTML] Could the underlying biological basis of prognostic radiomics and deep learning signatures be explored in patients with lung cancer? A systematic review
L Qian, T Wu, S Kong, X Lou, Y Jiang, Z Tan… - European Journal of …, 2024 - Elsevier
Objectives To summarize the underlying biological correlation of prognostic radiomics and
deep learning signatures in patients with lung cancer and evaluate the quality of available …
deep learning signatures in patients with lung cancer and evaluate the quality of available …
Machine learning in lung cancer radiomics
J Li, Z Li, L Wei, X Zhang - Machine Intelligence Research, 2023 - Springer
Lung cancer is the leading cause of cancer-related deaths worldwide. Medical imaging
technologies such as computed tomography (CT) and positron emission tomography (PET) …
technologies such as computed tomography (CT) and positron emission tomography (PET) …
A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics
X Wang, H Duan, X Li, X Ye, G Huang… - Physics in Medicine & …, 2020 - iopscience.iop.org
A prognostic analysis method for non-small cell lung cancer based on the computed tomography
radiomics - IOPscience This site uses cookies. By continuing to use this site you agree to our …
radiomics - IOPscience This site uses cookies. By continuing to use this site you agree to our …
A deep learning‐and CT image‐based prognostic model for the prediction of survival in non‐small cell lung cancer
W Chen, X Hou, Y Hu, G Huang, X Ye, S Nie - Medical Physics, 2021 - Wiley Online Library
Objective To assist clinicians in arranging personalized treatment, planning follow‐up
programs and extending survival times for non‐small cell lung cancer (NSCLC) patients, a …
programs and extending survival times for non‐small cell lung cancer (NSCLC) patients, a …